BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9328808)

  • 41. An exploratory study: the use of paroxetine for methamphetamine craving.
    Piasecki MP; Steinagel GM; Thienhaus OJ; Kohlenberg BS
    J Psychoactive Drugs; 2002; 34(3):301-4. PubMed ID: 12422941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimulant Use Disorders.
    Park TM; Haning WF
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):461-71. PubMed ID: 27338967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The CSAT methamphetamine treatment program: research design accommodations for "real world" application.
    Huber A; Lord RH; Gulati V; Marinelli-Casey P; Rawson R; Ling W
    J Psychoactive Drugs; 2000; 32(2):149-56. PubMed ID: 10908002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.
    Alammehrjerdi Z; Ezard N; Dolan K
    Asian J Psychiatr; 2018 Jan; 31():49-55. PubMed ID: 29414387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methamphetamine abuse: issues for special populations.
    Freese TE; Obert J; Dickow A; Cohen J; Lord RH
    J Psychoactive Drugs; 2000; 32(2):177-82. PubMed ID: 10908005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences between methamphetamine users and cocaine users in treatment.
    Copeland AL; Sorensen JL
    Drug Alcohol Depend; 2001 Mar; 62(1):91-5. PubMed ID: 11173172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The recent expansion in the Australian cocaine market: who are the new users and what are the harms?
    Chalmers J; Matthew-Simmons F; Hughes CE
    Curr Drug Abuse Rev; 2013 Jun; 6(2):98-111. PubMed ID: 24308523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of injecting and noninjecting methamphetamine users.
    Domier CP; Simon SL; Rawson RA; Huber A; Ling W
    J Psychoactive Drugs; 2000; 32(2):229-32. PubMed ID: 10908012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
    Sliman S; Waalen J; Shaw D
    Cardiovasc Toxicol; 2016 Oct; 16(4):381-9. PubMed ID: 26661075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multisite study of the effectiveness of methamphetamine treatment: an initiative of the Center for Substance Abuse Treatment.
    Herrell JM; Taylor JA; Gallagher C; Dawud-Noursi S
    J Psychoactive Drugs; 2000; 32(2):143-7. PubMed ID: 10908001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methamphetamine abuse: a perfect storm of complications.
    Lineberry TW; Bostwick JM
    Mayo Clin Proc; 2006 Jan; 81(1):77-84. PubMed ID: 16438482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cocaine abuse and dependence: the scope of the problem.
    Gottheil E
    Adv Alcohol Subst Abuse; 1986; 6(2):23-30. PubMed ID: 3496736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: A retrospective cohort study.
    Callaghan RC; Halliday M; Gatley J; Sykes J; Taylor L; Benny C; Kish SJ
    Drug Alcohol Depend; 2018 Jul; 188():259-265. PubMed ID: 29793190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence.
    Vocci FJ; Montoya ID
    Curr Opin Psychiatry; 2009 May; 22(3):263-8. PubMed ID: 19307968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methamphetamine-associated shock with intestinal infarction.
    Brannan TA; Soundararajan S; Houghton BL
    MedGenMed; 2004 Dec; 6(4):6. PubMed ID: 15775833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlates of outpatient drug treatment drop-out among methamphetamine users.
    Maglione M; Chao B; Anglin MD
    J Psychoactive Drugs; 2000; 32(2):221-8. PubMed ID: 10908011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.
    Nordahl TE; Salo R; Leamon M
    J Neuropsychiatry Clin Neurosci; 2003; 15(3):317-25. PubMed ID: 12928507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Methamphetamine--a drug of pregnant female drug addicts].
    Slamberová R; Charousová P
    Cesk Fysiol; 2008; 57(1):15-23. PubMed ID: 18630140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A change of patients with methamphetamine-related disorders admitted to Tokyo Metropolitan Matsuzawa Hospital--the comparison between the second and third epidemics of methamphetamine abuse in Japan].
    Aikawa Y; Ogai Y; Morita N; Umeno M; Okada N; Ikeda T; Umezu H; Senoo E; Nakatani Y; Okazaki Y
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Apr; 47(2):57-67. PubMed ID: 22746037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methamphetamine and the expanding complications of amphetamines.
    Albertson TE; Derlet RW; Van Hoozen BE
    West J Med; 1999 Apr; 170(4):214-9. PubMed ID: 10344175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.